138 related articles for article (PubMed ID: 29936558)
1. Chemical shift imaging with in-phase and opposed-phase sequences at 3 T: what is the optimal threshold, measurement method, and diagnostic accuracy for characterizing marrow signal abnormalities?
Kumar NM; Ahlawat S; Fayad LM
Skeletal Radiol; 2018 Dec; 47(12):1661-1671. PubMed ID: 29936558
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Performance of In-Phase and Opposed-Phase Chemical-Shift Imaging for Differentiating Benign and Malignant Vertebral Marrow Lesions: A Meta-Analysis.
Suh CH; Yun SJ; Jin W; Park SY; Ryu CW; Lee SH
AJR Am J Roentgenol; 2018 Oct; 211(4):W188-W197. PubMed ID: 30160981
[TBL] [Abstract][Full Text] [Related]
3. Utilization of chemical shift MRI in the diagnosis of disorders affecting pediatric bone marrow.
Winfeld M; Ahlawat S; Safdar N
Skeletal Radiol; 2016 Sep; 45(9):1205-12. PubMed ID: 27179650
[TBL] [Abstract][Full Text] [Related]
4. Comparison of in-phase and opposed-phase T1W gradient echo and T2W fast spin echo dixon chemical shift imaging for the assessment of non-neoplastic, benign neoplastic and malignant marrow lesions.
Saifuddin A; Shafiq H; Malhotra K; Santiago R; Pressney I
Skeletal Radiol; 2021 Jun; 50(6):1209-1218. PubMed ID: 33196854
[TBL] [Abstract][Full Text] [Related]
5. In-phase and opposed-phase Dixon chemical shift imaging for the assessment of skeletal marrow lesions: comparison of measurements from longitudinal sequences to those from axial sequences.
Saifuddin A; Ali M; Santiago R; Pressney I
Br J Radiol; 2024 Mar; 97(1156):828-833. PubMed ID: 38321150
[TBL] [Abstract][Full Text] [Related]
6. Role of in-phase and out-of-phase chemical shift MRI in differentiation of non-neoplastic versus neoplastic benign and malignant marrow lesions.
van Vucht N; Santiago R; Pressney I; Saifuddin A
Br J Radiol; 2021 Mar; 94(1119):20200710. PubMed ID: 33571012
[TBL] [Abstract][Full Text] [Related]
7. Chemical shift imaging at 3 Tesla: effect of echo time on assessing bone marrow abnormalities.
Del Grande F; Subhawong T; Flammang A; Fayad LM
Skeletal Radiol; 2014 Aug; 43(8):1139-47. PubMed ID: 24744013
[TBL] [Abstract][Full Text] [Related]
8. Anomalous signal intensity increase on out-of-phase chemical shift imaging: a manifestation of marrow mineralisation?
van Vucht N; Santiago R; Pressney I; Saifuddin A
Skeletal Radiol; 2020 Aug; 49(8):1269-1275. PubMed ID: 32198527
[TBL] [Abstract][Full Text] [Related]
9. Differentiation between focal malignant marrow-replacing lesions and benign red marrow deposition of the spine with T2*-corrected fat-signal fraction map using a three-echo volume interpolated breath-hold gradient echo Dixon sequence.
Kim YP; Kannengiesser S; Paek MY; Kim S; Chung TS; Yoo YH; Yoon CS; Song HT; Lee YH; Suh JS
Korean J Radiol; 2014; 15(6):781-91. PubMed ID: 25469090
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness of opposed-phase gradient-echo technique in the diagnosis of occult lesions of the knee and comparison with traditional T1-weight sequences (in-phase)].
Zampa V; Carafoli D; Grassi L; Cosottini M; Trippi D; Ortori S; Bagnolesi P
Radiol Med; 2000; 99(1-2):31-5. PubMed ID: 10803183
[TBL] [Abstract][Full Text] [Related]
11. Gradient-echo in-phase and opposed-phase chemical shift imaging: role in evaluating bone marrow.
Dreizin D; Ahlawat S; Del Grande F; Fayad LM
Clin Radiol; 2014 Jun; 69(6):648-57. PubMed ID: 24613580
[TBL] [Abstract][Full Text] [Related]
12. Chemical shift imaging: preliminary experience as an alternative sequence for defining the extent of a bone tumor.
Del Grande F; Tatizawa-Shiga N; Jalali Farahani S; Chalian M; Fayad LM
Quant Imaging Med Surg; 2014 Jun; 4(3):173-80. PubMed ID: 24914418
[TBL] [Abstract][Full Text] [Related]
13. Advanced MR imaging of bone marrow: quantification of signal alterations on T1-weighted Dixon and T2-weighted Dixon sequences in red marrow, yellow marrow, and pathologic marrow lesions.
Sasiponganan C; Yan K; Pezeshk P; Xi Y; Chhabra A
Skeletal Radiol; 2020 Apr; 49(4):541-548. PubMed ID: 31606776
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of chemical shift MR imaging in diagnosing indeterminate bone marrow lesions in the pelvis: review of a single institution's experience.
Kohl CA; Chivers FS; Lorans R; Roberts CC; Kransdorf MJ
Skeletal Radiol; 2014 Aug; 43(8):1079-84. PubMed ID: 24781818
[TBL] [Abstract][Full Text] [Related]
15. Focal nodular marrow hyperplasia: Imaging features of 53 cases.
Rajakulasingam R; Saifuddin A
Br J Radiol; 2020 Aug; 93(1112):20200206. PubMed ID: 32463293
[TBL] [Abstract][Full Text] [Related]
16. Contrast-Enhanced Dixon Fat-Water Separation Imaging of the Spine: Added Value of Fat, In-Phase and Opposed-Phase Imaging in Marrow Lesion Detection.
Zhadanov SI; Doshi AH; Pawha PS; Corcuera-Solano I; Tanenbaum LN
J Comput Assist Tomogr; 2016; 40(6):985-990. PubMed ID: 27331928
[TBL] [Abstract][Full Text] [Related]
17. Predicting osteomyelitis in patients whose initial MRI demonstrated bone marrow edema without corresponding T1 signal marrow replacement.
Sax AJ; Halpern EJ; Zoga AC; Roedl JB; Belair JA; Morrison WB
Skeletal Radiol; 2020 Aug; 49(8):1239-1247. PubMed ID: 32130445
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging of musculoskeletal lesions: comparison of three fat-saturation pulse sequences.
Pui MH; Goh PS; Choo HF; Fok EC
Australas Radiol; 1997 May; 41(2):99-102. PubMed ID: 9153802
[TBL] [Abstract][Full Text] [Related]
19. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.
Péporté AR; Sommer WH; Nikolaou K; Reiser MF; Zech CJ
Eur J Radiol; 2013 Mar; 82(3):e101-6. PubMed ID: 23159401
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of chemical shift MRI for differentiating diffuse red bone marrow reconversion and hematological malignancies.
Akman B; Ata Korkmaz HA; Sarı A
Turk J Med Sci; 2019 Apr; 49(2):644-652. PubMed ID: 30889945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
